Analysts Anticipate Alcentra Capital Corp. (ABDC) to Post $0.33 Earnings Per Share
Analysts expect Alcentra Capital Corp. (NASDAQ:ABDC) to post $0.33 earnings per share (EPS) for the current quarter, Zacks reports. Five analysts have issued estimates for Alcentra Capital Corp.’s earnings. The lowest EPS estimate is $0.32 and the highest is $0.34. Alcentra Capital Corp. posted earnings per share of $0.35 during the same quarter last year, which suggests a negative year over year growth rate of 5.7%. The business is expected to report its next earnings results on Thursday, November 2nd.
On average, analysts expect that Alcentra Capital Corp. will report full-year earnings of $1.37 per share for the current fiscal year, with EPS estimates ranging from $1.33 to $1.43. For the next fiscal year, analysts forecast that the company will report earnings of $1.38 per share, with EPS estimates ranging from $1.29 to $1.49. Zacks’ EPS calculations are a mean average based on a survey of sell-side analysts that that provide coverage for Alcentra Capital Corp..
A number of brokerages have commented on ABDC. Raymond James Financial, Inc. cut shares of Alcentra Capital Corp. from a “strong-buy” rating to an “outperform” rating and reduced their target price for the company from $16.00 to $14.00 in a report on Monday, July 17th. ValuEngine cut shares of Alcentra Capital Corp. from a “buy” rating to a “hold” rating in a report on Friday, September 1st. Keefe, Bruyette & Woods set a $14.00 target price on shares of Alcentra Capital Corp. and gave the company a “hold” rating in a report on Wednesday, May 31st. TheStreet cut shares of Alcentra Capital Corp. from a “b” rating to a “c+” rating in a report on Monday, July 24th. Finally, DA Davidson began coverage on shares of Alcentra Capital Corp. in a report on Wednesday, July 5th. They set a “buy” rating and a $15.00 target price for the company. Five investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Alcentra Capital Corp. currently has a consensus rating of “Hold” and an average target price of $13.50.
In other news, Director Steven H. Reiff acquired 11,668 shares of Alcentra Capital Corp. stock in a transaction dated Monday, August 7th. The stock was purchased at an average cost of $10.72 per share, with a total value of $125,080.96. Following the completion of the purchase, the director now directly owns 7,000 shares in the company, valued at approximately $75,040. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 4.96% of the company’s stock.
Several hedge funds and other institutional investors have recently made changes to their positions in the company. Oppenheimer & Co. Inc. increased its stake in shares of Alcentra Capital Corp. by 4.4% in the second quarter. Oppenheimer & Co. Inc. now owns 13,098 shares of the asset manager’s stock worth $178,000 after purchasing an additional 550 shares in the last quarter. Wells Fargo & Company MN increased its stake in shares of Alcentra Capital Corp. by 4.9% in the first quarter. Wells Fargo & Company MN now owns 28,835 shares of the asset manager’s stock worth $396,000 after purchasing an additional 1,354 shares in the last quarter. Carnegie Capital Asset Management LLC increased its stake in shares of Alcentra Capital Corp. by 8.1% in the second quarter. Carnegie Capital Asset Management LLC now owns 20,011 shares of the asset manager’s stock worth $232,000 after purchasing an additional 1,500 shares in the last quarter. Confluence Investment Management LLC increased its stake in shares of Alcentra Capital Corp. by 2.7% in the second quarter. Confluence Investment Management LLC now owns 209,528 shares of the asset manager’s stock worth $2,847,000 after purchasing an additional 5,566 shares in the last quarter. Finally, Royal Bank of Canada increased its stake in shares of Alcentra Capital Corp. by 1,948.4% in the second quarter. Royal Bank of Canada now owns 8,808 shares of the asset manager’s stock worth $120,000 after purchasing an additional 8,378 shares in the last quarter. 31.49% of the stock is owned by hedge funds and other institutional investors.
COPYRIGHT VIOLATION NOTICE: This piece was originally posted by Daily Political and is the property of of Daily Political. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of US and international copyright & trademark legislation. The correct version of this piece can be read at https://www.dailypolitical.com/2017/09/16/analysts-anticipate-alcentra-capital-corp-abdc-to-post-0-33-earnings-per-share.html.
Alcentra Capital Corp. (NASDAQ ABDC) traded up 1.11% on Friday, reaching $10.94. 60,906 shares of the company traded hands. The stock’s 50-day moving average is $10.88 and its 200-day moving average is $12.84. Alcentra Capital Corp. has a 1-year low of $10.20 and a 1-year high of $14.73.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 5th. Stockholders of record on Saturday, September 30th will be paid a $0.34 dividend. The ex-dividend date is Thursday, September 28th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 12.43%. Alcentra Capital Corp.’s dividend payout ratio (DPR) is presently -1,700.00%.
About Alcentra Capital Corp.
Alcentra Capital Corporation is a specialty finance company that operates as a non-diversified, closed-end management investment company. The Company operates as a business development company and a regulated investment company. It provides customized debt and equity financing solutions to lower middle-market companies, which are companies having annual earnings, before interest, taxes, depreciation and amortization of between $5 million and $15 million, and/or revenues of between $10 million and $100 million.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Alcentra Capital Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital Corp. and related companies with MarketBeat.com's FREE daily email newsletter.